<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="75457">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01792544</url>
  </required_header>
  <id_info>
    <org_study_id>SUIRB-021780</org_study_id>
    <nct_id>NCT01792544</nct_id>
  </id_info>
  <brief_title>Clinical Reminders in Test Reports to Improve Guideline Compliance</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Palo Alto Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Palo Alto Health Care System</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study examines the impact of adding a statement to the echocardiography report that
      advises anyone reading the report regarding if and when a follow-up study is recommended.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Inappropriate follow-up</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Performance of a follow-up echocardiogram when it was not indicated or not performing for a follow-up echocardiogram when it was indicated.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Echocardiography</condition>
  <arm_group>
    <arm_group_label>Statement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A statement is added to the echocardiography report describing if and when a follow-up echocardiogram is recommended.  The statement may be positive (e.g. follow-up recommended in 6 months) or negative (e.g. no follow-up recommended).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Statement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No statement is added to the echocardiography report</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Statement</intervention_name>
    <arm_group_label>Statement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Statement</intervention_name>
    <arm_group_label>No Statement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All patients undergoing echocardiography where the physician creating the report feels a
        comment is appropriate regarding when follow-up should or should not occur.

        Exclusion Criteria:

        None.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>VA Palo Alto HCS</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 2, 2013</lastchanged_date>
  <firstreceived_date>February 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VA Palo Alto Health Care System</investigator_affiliation>
    <investigator_full_name>Paul Heidenreich</investigator_full_name>
    <investigator_title>Staff Physician</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
